By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.
Contact Us   |   Groups   |   Print Page   |   Sign In   |   Join APSHO
Industry Council

Contact Us about becoming an Industry Council Member

The Industry Council offers advanced practitioners the opportunity to share their unique perspective on their daily roles, responsibilities, and challenges, with their colleagues in the pharmaceutical and manufacturing industries. To view our 2019 Industry Council brochure please see here.

APSHO greatly appreciates the support provided by the following companies for advancing the society’s mission.

 

 

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to improve treatments across four therapeutic areas: immunology, oncology, virology and neuroscience.   Follow @abbvie on Twitter, Facebook or LinkedIn or visit www.abbvie.com

  Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. www.amgen.com
   

Through scientific innovation and collaboration, Boehringer Ingelheim is committed to discovering and developing novel cancer treatments for patients in areas of high unmet medical need. We seek out strong partnerships and remain dedicated to expanding our portfolio of treatments in both solid tumors and hematological cancers. We are proud of our unique approach to research and discovery which is currently focused on angiogenesis inhibition, signal transduction inhibition, cell-cycle kinase inhibition, immunotherapy, apoptosis, epigenetics and protein homeostasis.

For more information please visit www.us.boehringer-ingelheim.com, or follow us on Twitter @BoehringerUS

  Bristol-Myers Squibb Company is committed to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.  To our patients and customers, employees, global communities, shareholders, environment and other stakeholders, we promise to act on our belief that the priceless ingredient of every product is the integrity of its maker. www.bms.com
  Celgene Corporation (Nasdaq:CELG) is a global biopharmaceutical company that is helping healthcare providers turn incurable cancers into chronic, manageable diseases, as well as manage serious inflammatory conditions through innovative therapies. This dedication to medical progress goes hand-in-hand with our industry-leading patient support and access programs. Together, these aspects form the core of our commitment to patients worldwide. For more information, visit www.celgene.com

Founded more than 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit www.gene.com.
Helsinn is a privately owned pharmaceutical group headquartered in Lugano, Switzerland, with operating subsidiaries in Ireland, the U.S. and an office in China. Helsinn is one of the world’s leading supportive cancer care companies. Our vision is to help people with cancer get the most of every day. We make everything we do, from the products we license or develop, to our exacting manufacturing standards count towards improving the lives of people with cancer. www.helsinn.com
  Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com
  Pfizer Oncology is committed to pursuing innovative treatments that are helping to redefine life with cancer. As an oncology leader with one of the most robust oncology pipelines in the industry, we are focused on translating scientific breakthroughs into clinical application. Additionally, we are dedicated to working collaboratively with the community to make a positive impact on people’s lives. Learn more about Pfizer Oncology here. 
 

Pharmacyclics, an AbbVie company, is located in Sunnyvale, California, and is focused on developing and commercializing innovative small-molecule therapies for the treatment of certain cancers and immune-mediated diseases. Our hope is that we can change or improve the standard of care for the disease areas we treat or study to continually advance cancer care for patients. www.pharmacyclics.com


Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care.

Puma is dedicated to advancing the treatment of HER2+ breast cancer and supporting women, their families and the breast cancer community. www.PumaBiotechnology.com
  Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.



Membership Management Software Powered by YourMembership  ::  Legal